¡ã Çѱ¹¾àÁ¦ÇÐȸ°¡ 21ÀÏ ¼¿ï´õÄÉÀÌÈ£ÅÚ¿¡¼ '2019 Çѱ¹¾àÁ¦ÇÐȸ ÃÑȸ ¹× ±¹Á¦Çмú´ëȸ'¸¦ °³ÃÖÇß´Ù. ( »çÁø Eric Chan (National Univ. of Singapore) ±³¼ö)
'»ý¾àÁ¦ ºÐ·ù ½Ã½ºÅÛ¿¡ ´ëÇÑ »çÀü °í·Á »çÇ×-Ä¿Æñâ¼ú ºÎ¹® ù ¹ßÇ¥ Åä·Ð'
Çѱ¹-¹Ì±¹-ÀϺ»-½Ì°¡Æ÷¸£-Áß±¹-Àεµ-³×´ú·±µå-µ§¸¶Å©-Çë°¡¸® µî¼ Âü°¡
»ç´Ü¹ýÀÎ Çѱ¹¾àÁ¦ÇÐȸ(ȸÀå À̹üÁø ±³¼ö.¾ÆÁÖ¾à´ëÇÐÀå)°¡ '2019³â Çѱ¹¾àÁ¦ÇÐȸ ÃÑȸ ¹× ±¹Á¦Çмú´ëȸ'¸¦ °³ÃÖÇß´Ù.
À̹ø Çмú´ëȸ´Â 21ÀϺÎÅÍ 22ÀϱîÁö ÀÌƲ°£ ¼¿ï ´õÄÉÀÌÈ£ÅÚ¿¡¼ ¡®Dynamic Revolutions in Pharmaceutical Sciences and Technology¡¯¶ó´Â ÁÖÁ¦·Î °³ÃÖµÆÀ¸¸ç, Çѱ¹¾àÁ¦ÇÐȸ°¡ ÁÖ°üÇÏ°í ½ÄÇ°ÀǾàÇ°¾ÈÀüó, Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇùȸ, Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ°¡ ÈÄ¿øÇß´Ù.
21ÀÏ Ã¹³¯ Çмú´ëȸ¿¡¼´Â Â÷¼¼´ë ¿¬±¸ÀÚ À°¼º ¹× Áö¿øÀ» À§ÇØ ¡®Preformulation considerations for biopharmaceutics classification system (BCS)¡¯ À̶ó´Â ÁÖÁ¦·Î Cutting-edge techniques in solubility evaluation, Recent solidification technologies for liquid-based formulations, Challenges to improve the biopharmaceutical properties of BCS Class III/IV candidates and drug development strategy, How to prepare for a job interview & How to build a successful career¶ó´Â ÁÖÁ¦ÀÇ ±³À° ÇÁ·Î±×·¥À» ÁøÇàÇß´Ù.
ÀÌ ÇÁ·Î±×·¥Àº ÇÐȸ Âü°¡µî·ÏÀÚ Áß ½ÅûÀڵ鿡°Ô º°µµÀÇ ¼ö°·á ¾øÀÌ ¹«·á·Î Á¦°øµÆ´Ù.
ÀÌ¾î¼ ¹Ì±¹ KIST-Dana Farber Cancer Institute ±ÇÀÍÂù ±³¼öÀÇ ±âÁ¶°¿¬°ú Steven reed (IDRI), Yoon Yeo (Purdue Univ.), Jukka Rantanen (Univ. of Copenhagen), Huile Gao (Sichuan Univ.), Jaewoon Son(GC Pharma), Shirui Mao (Shenyang Pharmaceutical Univ.), Eric Chan (National Univ. of Singapore), Frantisek Stepanek (Univ. of Chemistry and Technology in Prague), Jee Eun Lee (GC Pharma), Dong-Seok Yim (The Catholic Univ. of Korea), Vijay Kulkarni (STEER Life), Kenjirou Higashi (Chiba Univ.)µî ÃÊû¿¬ÀÚµéÀÇ °ÀÇ°¡ À̾îÁ³´Ù.
¶Ç ÇÐȸ ¹× Á¦¾à »ê¾÷¿¡ ¹ßÀü¿¡ ±â¿©ÇØ °øÇåÀÌ Å« Á÷¿ªÀεéÀ» À§ÇÑ ½Ã»ó°ú ¸¸Âùµµ Á¦°øµÆ´Ù.
Çà»ç¸¦ ÁÖ°üÇÑ Çѱ¹¾àÁ¦ÇÐȸ À̹üÁø ȸÀå(¢¸»çÁø)Àº "¾î¶² Á¦³×¸¯ÀÌµç ¾àÁ¦ÇÐÀû ±â¹ÝÀÇ ±â¼ú°ú ³ëÇÏ¿ì°¡ µé¾î°¡Áö ¾ÊÀ¸¸é Àý´ë·Î ±Û·Î¹ú¼ºÀåÇÒ¼ö ¾ø´Ù."°í ÁöÀûÇÏ°í, "±â¼úÀû ¹ßÀü »Ó¸¸¾Æ´Ï¶ó ¾àÈ¿ Ç°ÁúÀ» Æ÷ÇÔÇؼ Çö½ÇÀûÀ¸·Î ¸¹Àº ¹®Á¦°¡ ¹ß»ýÇÏ°í ÀÖ´Ù"°í ¸»Çß´Ù.
ÀÌ¾î¼ "Çѱ¹¾àÁ¦ÇÐȸ°¡ ÀÌ·¸°Ô ¼ºÀåÇѵ¥¿¡´Â ¿©·¯ ȸ¿øµé°ú ±³¼ö´ÔµéÀÇ º¸ÀÌÁö¾Ê´Â ³ë°í¿Í »ê¾÷ü, ½Ä¾àó µîÀÇ ¸¹Àº µµ¿òÀÌ ÀÖ¾ú±â ¶§¹®" À̶ó¸ç "¾ÕÀ¸·Îµµ ÇÐȸ°¡ È¥ÀÚ ÀÖ´Â °ÍÀÌ ¾Æ´Ï¶ó ¸¹Àº ±â°ü°úÀÇ Çù·Â, Á¦¾à¹ßÀüÀ» À§ÇÑ È¸¿øµéÀÇ ³ë°í, ÇÐȸ ¹ßÀüÀ» À̲ø°í ÀÖ´Â ¿©·¯ ÀÓ¿ø´ÔµéÀÇ ³ë°í°¡ ³ì¾Æ¾ß¸¸ ´õ¿í ´õ ±¹°¡»çȸ¿¡ ±â¿©ÇÒ ¼ö ÀÖÀ¸¸ç µ¿¹Ý¼ºÀå ÇÒ ¼ö ÀÖÀ»°Í"À̶ó°í ¸»Çß´Ù.
¾àÁ¦ÇÐȸ ¸í¿¹È¸ÀåÀÎ °´ö¿µ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à »çÀå(»çÁø ¢º)Àº "À¯³ªÀÌƼµå Á¦¾àÀº ¼¼°è¿¡¼ °¡Àå ¸¹Àº °³·®½Å¾àÀ» ¸¸µå´Â ȸ»ç°¡ µÆ´Ù."¸ç "ȸ»çÀÇ ¸¹Àº ¿¬±¸¿øµéÀÌ ¾àÁ¦ÇÐȸ ȸ¿øÀ¸·Î ÇÐȸ¿Í ÃֽŠÁ¤º¸¸¦ °øÀ¯ÇÏ°í ÀÖ´Ù"¸ç °¨»ç¸¦ Ç¥Çß´Ù.
¶Ç Çà»ç ÃàÇÏÂ÷ Âü¼®ÇÑ Çѱ¹Á¦¾àºñÀÌ¿ÀÇùȸ °¥¿øÀÏ »ó±Ù ºÎȸÀåÀº "Çѱ¹¾àÁ¦ÇÐȸ¿Í Á¦¾à¾÷°è°¡ ¸¹Àº Á¤º¸¸¦ °øÀ¯Çϱ⸦ Èñ¸ÁÇÑ´Ù"¸é¼ ÇùÁ¶¸¦ ´çºÎÇß´Ù.
À̹üÁø ¾àÁ¦ÇÐȸ ȸÀåÀº ³»³â¿¡ ȸÀå ¹ÙÅëÀ» À̾î¹Þ°ÔµÇ´Â ¿ÀÀÇö ±³¼ö(°¡Å縯´ë ¾à´ë)¸¦ ÇÐȸ Âü¼®Àڵ鿡°Ô ¼Ò°³Çß´Ù.
¾àÁ¦ÇÐ ºÎ¹®¿¡¼ ¸ðµÎ 16°³ÀÇ ÁÖÁ¦°¡ ¹ßÇ¥µÈ À̵鰣ÀÇ ÇÐȸ´Â 21ÀÏ 10½Ã °³¸·µÅ 22ÀÏ ¿ÀÈÄ 5½Ã±îÁö °è¼ÓµÆ´Ù.(±â»çÀÂÊ ÁÖ¿ä¹ßÇ¥³»¿ë Á¦¸ñ µî /¾Æ·¡´Â ¼¼ºÎ ÁøÇàÇ¥.).